Day to Day Variation in Fetal Heart Rate Variability

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05899101` - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed	`NCT04502823` - Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler	N/A
Not yet recruiting	`NCT03625518` - Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes	Early Phase 1
Completed	`NCT05176041` - SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome
Completed	`NCT02379728` - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth	N/A
Completed	`NCT01695070` - Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies	Phase 4
Completed	`NCT01352234` - Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia	Phase 4
Not yet recruiting	`NCT05284474` - Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler	N/A
Recruiting	`NCT03662178` - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Recruiting	`NCT05023161` - Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
Completed	`NCT02590536` - A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction	Phase 3
Not yet recruiting	`NCT05029778` - Arginine + Citrulline as a Supplement for Weight Gain in Fetus With a Decrease in Their Growth Curve	Phase 4
Recruiting	`NCT05576207` - BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)	N/A
Active, not recruiting	`NCT05160649` - Effect of Covid 19 Infection on Fetomaternal Outcome
Completed	`NCT02280031` - Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.	Phase 2
Recruiting	`NCT04389099` - MRI Angiography of Physiological and Pathological Pregnancy Placentas Ex-vivo
Recruiting	`NCT06039319` - Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
Recruiting	`NCT05651347` - Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction	Phase 3
Recruiting	`NCT02336243` - A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders	Phase 3
Active, not recruiting	`NCT01594463` - Routine Ultrasound Screening in the Third Trimester	N/A

NCT number	NCT04289350
Study type	Observational
Source	University of Aarhus
Contact
Status	Completed
Phase
Start date	September 1, 2018
Completion date	July 1, 2020

Day to Day Variation in Fetal Heart Rate Variability — (FHRV)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms